Data generated by the working group, which includes molecular profiling of over 10,000
tumors across 33
tumor types as well as a series of results on immune -
tumor interaction and response mechanisms, will provide
rich characterizations of the relationship between
tumors and the immune
microenvironment and its impact on patient outcomes.